2024 list of top U.S. biotech and pharmaceutical companies based on revenue

Based on revenues latest available as of 2024, Johnson & Johnson was the top ranked pharmaceutical company in the United States. Johnson & Johnson generated over 85 billion U.S. dollars worldwide, which is around 25 billion U.S. dollars more than the next ranked U.S. pharmaceutical company, Pfizer. However, Johnson & Johnson's total revenue includes also sales from their medical device and consumer health divisions, while Pfizer is a pure-play biopharmaceutical company.Branded and generic drugs: What are the differences?Patented products marketed by pharmaceutical companies are referred to as branded. The protection of the patent means that the company, which has spent a large amount of money researching and developing the product, can exclusively sell the drug – often at a high price to recoup its investment. Once the patent expires, other companies may produce generic versions of the product, which contain the same key ingredients.

依据截至2024年的最新营收数据，强生公司（Johnson & Johnson）位居美国制药企业之首。强生公司全球营收超过850亿美元，较排名第二的美国制药公司辉瑞（Pfizer）高出约250亿美元。然而，强生公司的总收入还包括其医疗设备和消费者健康部门的销售收入，而辉瑞则是一家专注于生物制药的纯企业。品牌药与仿制药：二者有何区别？由制药公司营销的专利产品被称为品牌药。专利保护意味着在产品研发上投入巨额资金的该公司能够独家销售该药物——通常以较高的价格来弥补其投资。一旦专利到期，其他公司即可生产该产品的仿制版本，这些仿制版本含有相同的核心成分。